Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiaitai is a Chinese biotechnology company specializing in the research, development, and large-scale production of small molecule peptides. The company focuses on extracting bioactive peptides from various natural sources, including bovine bone, fish, and plants, for use in health supplements and functional foods. Taiaitai operates significant manufacturing facilities and holds numerous patents related to peptide extraction and purification. Their product portfolio is designed to support immune health, skin rejuvenation, and overall physical recovery. By leveraging advanced enzymatic hydrolysis technology, the company has established itself as a key player in the global peptide nutraceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiaitaibiology.